Using 3D Imaging to Optimize Bifurcation Stenting

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 106 participants.

Also called NCT02972489

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 106 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02972489
Other papers using this trial's data
  • A Randomized Trial Evaluating Online 3-Dimensional Optical Frequency Domain Imaging-Guided Percutaneous Coronary Intervention in Bifurcation Lesions Circulation. Cardiovascular interventions, 2020-12 DOI, PubMed 33272034, PMC7732152 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Japan, Netherlands (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02972489. Randomized; no masking; primary purpose treatment. Start 2017-01 (registry gives no type); primary completion 2017-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Using 3D Imaging to Optimize Bifurcation Stenting
Condition
Bifurcation Lesion
Intervention (Device)
3D OFDI guidance arm
Intervention (Device)
Angio guidance arm
Lead sponsor
Increase Co., Ltd. (class: industry)
Collaborator
Fujita Health University (class: other)
Collaborator
Erasmus Medical Center (class: other)
Collaborator
Terumo Corporation (class: industry)

Record details

Record id
cardio:ct-nct02972489
Content hash
c1ad2a1f220b875538eee221c960d86682bc359ff0c58db04c656a0bf7416c97